Publication | Closed Access

Chronic lymphoid leukemia cells are highly sensitive to the combination of prednisolone and daunorubicin, but much less to doxorubicin or epirubicin

Hematological MalignancyLymphoid NeoplasiaMedicineHematologyImmunologyPathologyAdult T-cell Leukemia-lymphomaImmunotherapyOncology